Ajanta Pharma Limited (APL) (BSE: 532331 | NSE: AJANTPHARM) is an Indian multinational, engaged in development, manufacturing and marketing of pharmaceutical formulations. It has presence in India, USA and about 30 Emerging countries including Africa, Philippines, Rest of Asia, Middle East and CIS. Established in 1973.
Video Ajanta Pharma
Key Markets & Business
Company has over 1,400 products registered currently in various countries and equal number of products are under approval.
India Market
In India, company is a branded generic player focused on few high growth specialty therapies of Ophthalmology, Dermatology, Cardiology and Pain Management.
Emerging Markets
Company exports products to over 30 countries in Asia and Africa. In these markets, company serves a wide range of therapeutic segments of Anti Malaria, Cardio, GI, Antibiotic, Derma, Anti Histamine, Multivitamin, Gynaec, Pain Management, etc.
US Market
Company has recently stepped up its presence in the USA with a select product portfolio, which includes niche and complex technology products. Currently company has 16 products launched in the market and many
Maps Ajanta Pharma
Manufacturing Facilities
Ajanta Pharma operates 7 manufacturing facilities; 6 within India and 1 in Mauritius. In India, 5 facilities manufacture finished formulations, including Dahej and Paithan plants which is approved by US FDA and Guwahati plant which caters to domestic and emerging markets. Another 1 plant manufactures Active Pharmaceutical Ingredients (APIs) primarily for captive consumption.
References
External links
- Ajanta Pharma, "One of the Giants of Tomorrow" - Fortune India'
- Ajanta Pharma Ltd Listed in 'Forbes India - Super 50 Companies'
- Ajanta Pharma Ltd |Company Profile
Source of the article : Wikipedia
0 Comments